(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

FORMA CRISTALINA, COMPOSIÇÃO FARMACÊUTICA, USO DA FORMA CRISTALINA, E, MÉTODO PARA IMPEDIR OU TRATAR

Em AnáliseInvention PatentPCT · EP2024056495

Application data

Number

112025019259

Type

Invention Patent

Filing

03/12/2024

Publication

07/07/2026

PCT

EP2024056495

Progress at the INPI

Examination not yet requested
  1. Filing03/12/24
  2. Publication
  3. Examination
  4. Allowance
  5. Grant
  6. In force

Examination has not been requested yet. Without that request by 03/12/2027, the application is definitively abandoned (art. 33 of the Brazilian IP Act).

Deadline to request examination:03/12/2027(199 days left)

Leave your contact and we will alert you

We track INPI publications and let you know as soon as this case moves.

We use your details only for this alert.

Latest action published by the INPI: 07/07/2026. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

ASTRAZENECA AB

SE

See this company's full portfolio

Inventors

P. C. (pessoa física)

GB

Technical data

Priority claims

EP

23161547.7 · 03/13/2023

Abstract

FORMA CRISTALINA, COMPOSIÇÃO FARMACÊUTICA, USO DA FORMA CRISTALINA, E, MÉTODO PARA IMPEDIR OU TRATAR. O presente relatório descritivo se refere a uma forma cristalina de (3S)-2-[(5-amino-6-fluoro-1H-pirrolo[3,2-b]piridin-2-il)metil]-1'-but-2-inil-6-fluoro-espiro[isoindolina-3,3'-pirrolidina]-1,2'-diona, e a composições e usos das mesmas.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Notificação de entrada na fase nacional - PCT

#1.3

07/07/2026

RPI 2896

Alteração de dados cadastrais

#1.1

09/23/2025

RPI 2855

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.